We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$484B
AUM Growth
+$13.2B
Cap. Flow
-$3.88B
Cap. Flow %
-0.8%
Top 10 Hldgs %
13.39%
Holding
2,630
New
93
Increased
1,078
Reduced
887
Closed
93

Sector Composition

Rank Sector Weight
1 Healthcare 21.05%
2 Consumer Discretionary 13.82%
3 Financials 13.14%
4 Industrials 11.9%
5 Technology 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGG
2076
DELISTED
Briggs & Stratton Corp.
BGG
$378K ﹤0.01%
18,400
-8,000
-30% -$157K
CNOB icon
2077
Center Bancorp
CNOB
$1.82B
$377K ﹤0.01%
19,383
ORA icon
2078
Ormat Technologies
ORA
$6.98B
$376K ﹤0.01%
9,882
+482
+5% +$15.1K
GLD icon
2079
SPDR Gold Trust
GLD
$142B
$375K ﹤0.01%
3,300
ALCO icon
2080
Alico
ALCO
$303M
$374K ﹤0.01%
7,300
-300
-4% -$14.7K
PGRE
2081
DELISTED
Paramount Group
PGRE
$374K ﹤0.01%
+19,400
New +$369K
AX icon
2082
Axos Financial
AX
$5.76B
$372K ﹤0.01%
16,000
BTU
2083
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$372K ﹤0.01%
5,047
+1,974
+64% +$199K
MWW
2084
DELISTED
Monster Worldwide Inc
MWW
$372K ﹤0.01%
58,700
+12,800
+28% +$70.2K
SBY
2085
DELISTED
Silver Bay Realty Trust Corp.
SBY
$371K ﹤0.01%
22,983
ENPH icon
2086
Enphase Energy
ENPH
$5.37B
$369K ﹤0.01%
+27,980
New +$362K
AEGR
2087
DELISTED
Aegerion Pharmaceuticals
AEGR
$369K ﹤0.01%
14,100
+3,000
+27% +$76.3K
AIR icon
2088
AAR Corp
AIR
$5.84B
$368K ﹤0.01%
12,000
BGS icon
2089
B&G Foods
BGS
$295M
$368K ﹤0.01%
12,500
PENN icon
2090
PENN Entertainment
PENN
$2.52B
$367K ﹤0.01%
23,434
-5,510
-19% -$86.6K
NWLIA
2091
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
$366K ﹤0.01%
1,440
-100
-6% -$25.4K
DIN icon
2092
Dine Brands
DIN
$447M
$364K ﹤0.01%
3,400
SGI
2093
DELISTED
Silicon Graphics Intl.
SGI
$363K ﹤0.01%
41,800
+1,000
+2% +$9.85K
RPTP
2094
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$363K ﹤0.01%
33,400
+6,400
+24% +$65.3K
BCO icon
2095
Brink's
BCO
$4.68B
$361K ﹤0.01%
13,049
EWY icon
2096
iShares MSCI South Korea ETF
EWY
$27.7B
$361K ﹤0.01%
6,300
+2,100
+50% +$118K
PGC icon
2097
Peapack-Gladstone Financial
PGC
$826M
$361K ﹤0.01%
16,697
+4,400
+36% +$85.8K
NPKI
2098
NPK International
NPKI
$1.19B
$360K ﹤0.01%
39,500
QTS
2099
DELISTED
QTS REALTY TRUST, INC.
QTS
$360K ﹤0.01%
+9,900
New +$367K
LSCC icon
2100
Lattice Semiconductor
LSCC
$18.4B
$359K ﹤0.01%
56,600

Similar funds

T. Rowe Price Associates's Q1 2015 Portfolio in Review

As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
  • T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
  • T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
  • T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
  • T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.